Lonza

Lonza to Produce Bluebird Bio Drug

Savitzky to Succeed Haag as Lonza CFO

Lonza Said to be in Bid to Acquire Catalent

Borgas Frontrunner for Syngenta CEO?

Lonza Expands Drug Product Services

Lonza Expands UK Mammalian Production

Topics • Strategy

Global Chemicals Markets Still Volatile and Challenging

Lonza Acquires New Zealand’s Zelam

Lonza Signs New Agreement with Alexion

Lonza to Build Viral Therapy Plant in Texas

Nikon and Lonza Cooperate on Regenerative Therapeutics

Topics • Strategy

Chemical Players Expect Gains on Cheap Oil and Euro

Lonza and Tigenix Sign Toll Manufacture Agreement

Lonza Says Transformation Still on Track

Bristol-Myers Squibb and Lonza Extend Biologics Agreement

US Sets Import Duties on Chinese Chlorination Chemicals

Lonza Upgrades ADC Operations at Visp Plant

Sven Abend Named to Lonza Executive Committee

Global Chemical Industry Presents Mixed Results for 2013

Catalent Announces Two Senior Appointments to Expand Biologics Business

Swiss Anti-Immigration Vote Could Impact Chemical Sector

The Biosimilar Market

Lonza’s Corporate Overhaul

Topics • Technology

Highly Potent API Demand is On the Rise

Lonza Business Performance on Track

Teva - Lonza Evaluates Biosimilars Opportunity

Roche Stays a Step Ahead of Copycat Drugmakers

Lonza, Hyglos Reach Agreement for Endotoxin Detection Patents

Lonza Awarded Contract to Generate Research Grade iPSCs

Lonza Confirms 2015 Targets

Lonza, BaroFold Announce Technology Evaluation Agreement for PreEMT

Sartorius, Lonza Announce Collboration on Cell Culture Media

Switzerland's Lonza to Cut 500 Jobs

Lonza, OncoMed to Collaborate on Anti-Cancer Therapeutics

Cobra Biologics Appoints John Birch Non-Executive Director

34 more articles

Top-Feature

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Brenntag Downsizes Management Board, Retains Both Divisions

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

JMP Statistical Discovery / SAS Institute GmbH

From Data to Decisions: Digital Tools Reshaping the Chemical and Life Sciences Landscape

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Easyfairs Deutschland GmbH

Leading the way. Driving results.

Dow Chemical Company

Anchored in Sustainability

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

Leading Transformation

Expert Insights

Dual‑Targeting Breakthroughs

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Global Gateway Advisors

Camelot Management Consultants AG

Jan Ramakers Fine Chemical

GETEC Group

Frost & Sullivan

Pricewaterhouse Coopers

DCAT - Drug, Chemical & Associated Technologies Association

Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences

Fraser Dove International

Microinnova Engineering GmbH

PP Consulting

Mack Brooks Exhibition Ltd – Part of RX

F. Hoffmann-La Roche Ltd

Thomson Reuters